Alum Past Earnings Performance
Past criteria checks 0/6
Alum's earnings have been declining at an average annual rate of -77.3%, while the Chemicals industry saw earnings growing at 7.2% annually. Revenues have been declining at an average rate of 39.2% per year.
Key information
-77.3%
Earnings growth rate
-102.4%
EPS growth rate
Chemicals Industry Growth | 39.7% |
Revenue growth rate | -39.2% |
Return on equity | -56.5% |
Net Margin | -29.4% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Revenue & Expenses Breakdown
How Alum makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 206 | -61 | 25 | 0 |
31 Mar 24 | 248 | -103 | 27 | 0 |
31 Dec 23 | 285 | -145 | 28 | 0 |
30 Jun 23 | 470 | -185 | 52 | 0 |
31 Mar 23 | 556 | -142 | 60 | 0 |
31 Dec 22 | 500 | 16 | 29 | 0 |
30 Sep 22 | 707 | -50 | 77 | 0 |
30 Jun 22 | 771 | -2 | 73 | 0 |
31 Mar 22 | 797 | -20 | 75 | 0 |
31 Dec 21 | 823 | -39 | 78 | 0 |
30 Sep 21 | 802 | -7 | 77 | 0 |
30 Jun 21 | 780 | 25 | 76 | 0 |
31 Mar 21 | 751 | 53 | 75 | 0 |
31 Dec 20 | 722 | 81 | 73 | 0 |
31 Dec 19 | 861 | 83 | 75 | 0 |
31 Dec 18 | 928 | 55 | 77 | 0 |
31 Dec 17 | 710 | 87 | 65 | 0 |
31 Dec 16 | 588 | -6 | 54 | 0 |
31 Dec 15 | 643 | 18 | 50 | 0 |
31 Dec 14 | 543 | 31 | 47 | 0 |
31 Dec 13 | 518 | -83 | 44 | 0 |
Quality Earnings: BBGA is currently unprofitable.
Growing Profit Margin: BBGA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BBGA is unprofitable, and losses have increased over the past 5 years at a rate of 77.3% per year.
Accelerating Growth: Unable to compare BBGA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BBGA is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-6.3%).
Return on Equity
High ROE: BBGA has a negative Return on Equity (-56.52%), as it is currently unprofitable.